|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�ܰ���,Tϸ��,Ƥ�� |
|
���෨ |
|
Ԥ�� |
|
���� |
| ��������������� | |
|
��Ө |
|
֣�� |
| PubMed | |
|
Article by Li Ying |
|
Article by ZHENG Jie |
Ƥ��Tϸ���ܰ����ķ��ࡢԤ������
��Ө, ֣��
�Ϻ���ͨ��ѧҽѧԺ�������ҽԺƤ����, 200025
Ƥ��Tϸ���ܰ���������ǻ�����ܰ���,��CD4+�ļ����Ը���T�ܰ�ϸ����Ƥ���ϵĶ��Կ�¡������Ϊ����.��������WHO-EORTC����.��Ԥ�������䡢TNM���ڡ��ٴ����ڵȶ������ؾ���.Ƥ��Tϸ���ܰ��������Ʒ������ֶ���,���˳��õľֲ�����ҩ�ϵͳ��ҩ�Ｐ����������,Ŀǰ����һЩ�����ٴ�����ε����Ʒ���.
Classification,prognosis and therapy of cutaneous T cell lymphoma
Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Cutaneous T cell lymphoma(CTCL),a kind of extranodal non-Hodgkin lymphoma,is characterized by clonal malignancy of memory T helper cells in skin.It is classified according to the WHO-EORTC classification criteria.Its prognosis is dependant on patient's age,TNM staging,clinical stage and other factors.Treatment options for CTCL vary,including topical and systemic medicaments,as well as physiotherapy,and some therapies are still under clinical trials.